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We studied the interactions between conformers of exocellular a-amylase and small unilamellar vesicles (SUV) composed of the major
membrane lipids of Bacillus subtilis under physiological conditions of pH, temperature and ionic strength. Using fluorescence spectroscopy,
surface plasmon resonance (SPR) and phase separation, we show that the native a-amylase has no affinity for the SUV, whereas a partially
folded form, displaying structural properties in common with the competent state for secretion, binds to the vesicles (KAc 10
5 M 1). This
association prevented its subsequent folding. The complex was destabilized in the presence of PrsA, a major peripheric lipoprotein of B. subtilis
which displays a strong affinity for SUV (KAc 1.5 108 M 1). Vesicles coated with PrsA lost their ability to bind the partially folded
conformer.
The approach in vitro, in which our aimwas tomimic the last stage ofa-amylase translocation, indicates that PrsA possibly helps, in vivo, the
secreted protein to acquire its native conformation by modulating the interaction between the latter and the lipid polar heads on the trans side of
the cytoplasmic membrane.
D 2003 Elsevier B.V. All rights reserved.Keywords: Bacillus subtilis; Protein folding; Small unilamellar vesicle; Surface plasmon resonance; PrsA lipoprotein1. Introduction
The dynamics of folding plays a decisive role during the
translocation process undergone by imported or exported
proteins [1–3]. There is considerable evidence that translo-
cation involves a partially folded intermediate (competent
state) [4] which emerges on the extracellular side of the
translocation complex. However, it has been demonstrated,
in vitro, that protein conformers, which possess, like compe-
tent state, significant secondary structures but lack native
tertiary structure, exhibit membrane association properties
[5–7]. Such interactions could trap the partially folded
protein during its secretion in a cell-associated state, thus
preventing both its subsequent folding and its release into the
external medium. One can postulate that to avoid such an
eventuality, either the kinetics of folding transition is faster
than the membrane binding step or a membrane component0005-2736/$ - see front matter D 2003 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamem.2003.10.006
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E-mail address: chambert@ccr.jussieu.fr (R. Chambert).shields the partially folded protein from interactions with
lipid polar heads. To examine this hypothesis in the case of
the secretion mechanism of Bacillus subtilis, we propose here
an in vitro approach using small unilamellar vesicles (SUV)
composed of the main lipids that make up the B. subtilis
cytoplasmic membrane [8] and a-amylase as a model of
secreted protein. We have shown that a partially folded form
of this protein sharing common structural features with the
competent state for secretion can be stabilized under physi-
ological conditions of pH, temperature and ionic strength [9].
The strong interaction that we observed between the partially
folded conformer and SUV led us to search for a potential
modulator present on the trans side of the B. subtilis mem-
brane. The lipoprotein PrsAwas a good candidate. This major
extracytoplasmic protein is bound to the outer face of the
cytoplasmic membrane of B. subtilis [10]. It has been
suggested that it can function as an extracytoplasmic chap-
erone during the last stage of protein secretion [11]. But no
evidence documenting the in vitro activity of PrsA has yet
been published. Alternatively, it has been proposed [12] that
PrsA may protect secreted proteins from degradation either
by acting as a proteinase inhibitor or by shielding the newly
A. Colomer-Pallas et al. / Biochimica et Bsecreted proteins from proteinases. Interestingly, this abun-
dant protein, whose concentration remains unchanged
throughout growth phases (2–3 104 molecules per cell)
[13,14], can cover 15% to 20% of the outer surface of the
cytoplasmic membrane.
Using fluorescence spectroscopy, surface plasmon reso-
nance (SPR) and phase separation, we investigated the
interactions between partially folded a-amylase and SUV
and their modulation by PrsA. 
 
 
 
Fig. 1. Partition of native and partially folded conformers of a-amylase
between aqueous and lipid phases. (A) For each assay, a-amylase was first
totally unfolded by mixing 1.5 Al a-amylase stock solution (1 mg/ml) with
6 Al 6 M guanidium chloride. After 10-min incubation at 37 jC, the folding
intermediate was stabilized by diluting the denaturing mixture with 0.15 ml
0.2 M sodium acetate pH 7, 1 mM EDTA. After 1 min incubation, various
amounts of SUV stock suspension (2 mM lipid) were added. The lipid phase
of each sample was collected by centrifugation at 435,700 g after 5 min
incubation at 37 jC. The supernatants and resuspended pellets were analysed
by SDS-PAGE. (B) 1.5 Al of a-amylase stock solution (1 mg/ml) was mixed
with 0.15 ml 0.2 M sodium acetate pH 7, 1 mM EDTA, containing various
amounts of SUV. After 1 min incubation, the lipid phase of each sample was
collected as above. (C) Quantification of the percent of native (.) and
partially folded conformer (n) ofa-amylase in SUVpellet was obtained from
densitometric tracings of the Coomassie blue-stained gels.2. Materials and methods
2.1. Purification of exocellular a-amylase
a-Amylase was prepared from the culture supernatant of
B. subtilis GM96101 (degU32 (Hy), sacA321, DsacRsacB,
sacRamyE), a derivative of B. subtilis 168 [15]. A stock
solution of pure protein (10 mg/ml) was prepared in 0.1 M
potassium phosphate, pH 7.
2.2. Assay of a-amylase
a-Amylase activity was assayed at 37 jC, using p-nitro-
phenylmaltotrioside as substrate (bio-Merieux) at pH 6.3 in
0.1 M potassium phosphate. One enzyme unit corresponds to
25 Ag of pure a-amylase.
2.3. SUV preparation
A mixture of dry phospholipids (Sigma) was prepared
with 35% phosphatidyl-ethanolamine, diheptadecanoyl
(C17:0), 15% phosphatidyl-glycerol, dipalmitoyl (C16:0)
and 50% cardiolipin. This mixture was dissolved in chloro-
form and the lipids were deposited as a thin film by
removing the chloroform under a stream of nitrogen and
desiccated under high vacuum for 10 min to remove residual
chloroform. The lipids were dispersed in 0.2 M sodium
acetate, pH 7, by vortex mixing. The resultant lipid disper-
sion (5 ml) was then sonicated in an ultrasonicator using a
tungsten microtip (diameter of 3 mm) for 45 min (until
clear). Tungsten dust was removed by centrifuging the
homogenate for 10 min at 1250 g. The resulting vesicles
(SUV) were at a final lipid concentration of 2 mM.
2.4. SPR analysis
Biosensor experiments were carried out with a BIA-
core 2000 analytical system (Biacore, Uppsala, Sweden)
using an HPA sensor chip (Biacore) composed of long
chain alkanethiol molecules covalently linked to the gold
surface to form a hydrophobic monolayer. The running
buffer was 0.2 M sodium acetate pH 7, containing 1 mM
EDTA. All solutions were freshly prepared, degassed and
filtered through a 0.22 Am filter. All binding experiments
were carried out at 25 jC.2.5. Formation of monolayer membrane
The alkanethiol surface of the sensor chip HPA was
cleaned by injecting a solution of 40 mM octyl glucoside
(100 Al) at 10 Al/min. The suspension of SUV (0.5 mM)
was then injected over the chip surface at 2 Al/min. Any
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Fig. 2. SPR sensorgrams of the binding of native (a) and partially folded
conformers (b) of a-amylase to an immobilized lipid monolayer. A stable
lipid monolayer was prepared on the sensor chip as described in Materials
and methods. The kinetics of the association of a-amylase with the
monolayer was monitored by injecting the folding intermediate (a) or the
native form (b) (0.3 AM) at 20 Al/min. The a-amylase folding intermediate
was prepared as described in Materials and methods. Arrows 1 and 2
indicated the start and end of a-amylase injection.
A. Colomer-Pallas et al. / Biochimica et Biophysica Acta 1660 (2004) 16–2318multilamellar structures were removed from the lipid
surface by injecting sodium hydroxide (30 Al, 10 mM)
at 100 A1/min. This resulted in a stable baseline to give aFig. 3. Intrinsic fluorescence spectra of native and partially folded a-
amylase in the absence and presence of SUV. Intrinsic fluorescence spectra
of a-amylase were recorded at 37 jC in 0.2 M sodium acetate pH 7,
containing 1 mM EDTA. The final concentration of a-amylase was 0.15 AM
in each case. The excitation wavelength was 280 nm. (a) Native a-amylase,
(b) native a-amylase in the presence of SUV (lipid/protein molar ratio of
300), (c) folding intermediate and (d) folding intermediate in the presence of
SUV (lipid/protein molar ratio of 300). For (d), two traces of fluorescence
emission spectra were recorded at a time interval of 10 min. Protein spectra
were corrected by the spectrum of a reference solution without protein.response signal of 2400 RU [16]. The lipid surface was
used to study the protein binding to the lipid membrane.
2.6. Preparation in vitro of the a-amylase folding
intermediate
The folding intermediate of a-amylase was obtained by a
two-step procedure: First, the wholly unfolded form was 
Fig. 4. Intrinsic fluorescence changes of partially folded a-amylase in the
presence of SUV. An aliquot (l Al) of a-amylase stock solution (10 mg
ml 1) was mixed with 4 Al 6 M guanidium chloride. After 10 min
incubation at 37 jC, the denaturing mixture was diluted with 1 ml 0.1 M
sodium phosphate pH 7 containing 1 mM EDTA. (A) Kinetics of association
between SUVand a-amylase folding intermediate measured by fluorescence
intensity changes. The fluorescence intensity of the solution of a-amylase
folding intermediate (0.1 AM, pH 7, 37 jC) was recorded for 100 s. The
formation of the complex was promoted by adding (arrow) 20 Al SUV stock
suspension (lipid/a-amylase ratio of 300). The excitation wavelength was
280 nm and the emission wavelength 338 nm. (B) Fluorescence spectra of
a-amylase folding intermediate in the presence of various amounts of SUV.
A 0.15 AM solution of the folding intermediate was prepared as described in
Fig. 3, and the fluorescence spectra (excitation wavelength was 280 nm)
were recorded 5 min after each successive addition of 3 Al of SUV stock
suspension (2 mM lipid). The lipid/protein molar ratios tested were 0 to 300.
A. Colomer-Pallas et al. / Biochimica et Biophysica Acta 1660 (2004) 16–23 19obtained by mixing the native protein with 5 M guanidium
chloride for 10 min at pH 7 and 37 jC. The folding
intermediate was then obtained by diluting the denaturing
mixture 100 fold in acetate buffer pH 7, containing 1 mM
EDTA at 37 jC [9]. The second step of the refolding process
does not occur in the absence of free calcium, so that the
folding intermediate accumulated.
2.7. Fluorescence measurements
Changes in the intrinsic fluorescence and fluorescence
spectra of a-amylase were recorded with a F2000 Hitachi
thermoregulated spectrofluorimeter.3. Results
3.1. Partially folded B. subtilis a-amylase displays affinity
for SUV
We have previously defined the conditions under which a
folding intermediate of a-amylase is stabilized [9]. This
partially folded protein accumulated when a-amylase was
allowed to refold in the absence of calcium.Fig. 5. Refolding transition of a-amylase measured by intrinsic
fluorescence changes in the presence of SUV at 37 jC and pH 7.
Traces show the fluorescence intensity as a function of time (excitation
wavelength 280 nm, emission wavelength 338 nm). One microliter a-
amylase stock solution (10 mg ml 1) was mixed with 4 Al 6 M
guanidium chloride. After 10 min incubation at 37 jC, the denaturing
mixture was diluted with 1 ml 0.1 M sodium phosphate pH 7,
containing 0.5 mM calcium and various concentrations of SUV. (a) No
SUV added, (b) lipid/a-amylase ratio of 100 and (c) lipid/a-amylase
ratio of 300. a-Amylase activity was assayed using 5 Al aliquot of each
sample taken 3 h after the beginning of refolding.
Fig. 6. Partition of lipomodified PrsA and non-lipomodified PrsA between
aqueous and lipid phases. Five microliter stock solution (0.4 mg/ml) of
lipomodified PrsA (A) and 3 Al stock solution (0.7 mg/ml) of non-
lipomodified PrsA (B) were incubated with 60 Al 0.2 M sodium acetate
pH 7, 0.5 mM calcium plus SUV. After 15 min incubation at 37 jC, the
samples were then centrifuged at 435,700 g. The supernatants and
pellets were analysed by SDS-PAGE. (C) Quantification of the percent of
PrsA (n) and non-lipomodified PrsA (.) in SUV-pellet.We first investigated the interaction of this a-amylase
conformer with SUV by measuring the partition of the
protein between the aqueous and lipid phases at 37 jC
and pH 7. The amount of folding intermediate carried down
with the SUV-pellet increased as the ratio of lipid to protein
increased (Fig. 1A). In contrast, the native form of a-
amylase had no affinity for SUV (Fig. 1B).
The different interactions of the two conformers with the
lipid bilayer were examined by SPR (Fig. 2). The SPR signal
underwent a significant change when a solution of the folding
intermediate was injected over a lipid monolayer immobi-
lized on the sensor chip. In contrast, injection of native a-
amylase produced only a very small signal. The SPR sensor-
gram, however, showed that the association phase of the
folding intermediate binding was complex with multiphase
kinetics that prevented us measuring an association constant
Fig. 7. SPR sensorgram of the binding of lipomodified PrsA and non-
lipomodified PrsA to an immobilized lipid monolayer. Stable lipid
monolayer was formed on the sensor chip as described in Materials and
methods; the kinetics of protein association with the vesicles was monitored
by injecting (a) lipomodified PrsA (0.5 AM) or (b) non-lipomodified PrsA
(1 AM) at 2 Al/min. Arrows 1 and 2 indicate the start and end of protein
injection, respectively.
 
 
Fig. 8. Effect of increasing PrsA-SUV ratio on the ability of SUV to bind
the partially folded conformer of a-amylase. (A) SUV stock solution
(3.5 Al, 2 mM lipid) was diluted into 70 Al 0.2 M sodium acetate pH 7,
0.5 mM calcium containing increasing concentrations of lipomodified
PrsA. After 15 min incubation at 37 jC, unfolded a-amylase (1 Ag) was
then added to each sample. The mixtures were incubated for 10 min and
centrifuged at 435700 g. The pellets were solubilized into 70 Al 10%
SDS and analysed by SDS-PAGE. (B) The a-amylase activity in the
supernatants was measured as described in Materials and methods.
A. Colomer-Pallas et al. / Biochimica et B20even when attempts were made to fit these data to complex
binding interaction. We have to keep in mind that such a
quantitative analysis of binding is based on the hypothesis
that proteins did not aggregate on the biosensor surface. This
was probably not true for the folding intermediate since the
protein is prone to aggregate at high concentrations [17]. This
condition may prevail on the biosensor surface since it was
estimated that a signal of 1000 response units (RU) corre-
sponds to a protein surface concentration of approximately
10 mg ml 1 [18].
Specific interactions between the folding intermediate
of a-amylase and SUV can be demonstrated by the
changes in the intrinsic fluorescence properties of the
protein (Fig. 3). These experiments were carried out with
low protein concentrations to prevent aggregation [17].
The fluorescence intensity of native a-amylase was not
altered by adding SUV, suggesting that the quenching of
the partially folded a-amylase resulted from its interac-
tions with SUV. The association with SUV did not seem
to entail aggregation of the protein since no shift in the
maximum of its fluorescence emission spectrum was
observed (Fig. 3). This indicates that the protein was
adsorbed onto the SUV rather than inserted into the lipid
bilayer. Association was rapid, as demonstrated by the
quick change in intrinsic fluorescence of the a-amylase
folding intermediate subsequent to its mixing with SUV
(Fig. 4A). Association occurs during the dead time of the
manual mixing (5–8 s). The transition of the protein
binding was visualized by the gradual quenching of the
intrinsic fluorescence intensity that accompanied the in-
crease in the ratio of SUV to protein (Fig. 4B). An
affinity constant was calculated by fitting the fraction of
binding to lipid concentration (KAc 10
5) [19].3.2. The binding of folding intermediate to SUV prevented
its subsequent refolding
Refolding of the stabilized folding intermediate is readily
triggered by adding calcium at pH 7 and 37 jC as shown
previously [9]. Therefore, we tested the effect of increasing
SUV concentrations on the kinetics of refolding (Fig. 5) and
found that SUV prevented the refolding monitored by
recovering the fluorescence characteristic of the native a-
amylase state. This effect depended on the SUV concentra-
tion. Refolding was completely inhibited when all the
folding intermediate was complexed with SUV. Thus, asso-
ciation was faster than refolding and it prevented the
subsequent refolding of the protein. The recovery of a-
iophysica Acta 1660 (2004) 16–23
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intrinsic fluorescence properties (Fig. 5).
3.3. Native PrsA has a strong affinity for SUV
We tested the affinity of native PrsA for SUV using the
same techniques with the protein in its lipomodified or non-
lipomodified form [10]. Phase separation experiments (Fig.
6) showed that the lipomodified PrsA had a high affinity for
SUV. We determined the kinetics of PrsA binding to lipid
monolayer immobilized on the SPR biosensor from SPR
sensorgram (Fig. 7). This affinity was mainly due to the 
Fig. 9. Kinetics of a-amylase refolding in the presence of the SUV–PrsA comple
changes. SUV suspension (1 ml, 40 AM lipid) in 0.2 M sodium acetate pH 7, 1 mM
After 10 min incubation, 0.15 AM a-amylase folding intermediate was added and
wavelength was 280 nm. Control without a-amylase folding intermediate (b). (
degradation. SUV suspension (1 ml, 40 AM lipid) in 0.2 M sodium acetate pH 7, 1
jC. After 10 min incubation, 0.15 AM of a-amylase folding intermediate was add
with 1.5 Al subtilisin solution (1 mg/ml). After 5 min, 3 Al of 0.1 M PMSF was add
by densitometry of the Coomassie blue-stained gels using the NIH Image prograpresence of the lipid anchor as suggested by the results we
obtained with the protein devoid of its lipid anchor. The
affinity constant obtained by fitting the binding curve to a
simple model with two binding partners was 1.5 108 M 1
[20]. We calculated that the entire biosensor surface was
coated with PrsA from the magnitude of the SPR signal
change associated with the binding of the protein [16].
The association of PrsA with SUV did not alter the
intrinsic fluorescence properties of the protein (result not
shown), indicating that the protein was adsorbed onto the
lipid monolayer via its lipid anchor and that its tertiary
structure was not modified by the association. 
x. (A) Kinetics of a-amylase refolding measured by fluorescence intensity
calcium containing 0.25 AM of lipomodified PrsAwas incubated at 37 jC.
fluorescence intensity changes were recorded at 338 nm (a). The excitation
B) Kinetics of a-amylase refolding measured by resistance to proteolytic
mM calcium containing 0.25 AM of lipomodified PrsAwas incubated at 37
ed. Aliquots of 70 Al of this mixture were withdrawn at intervals and mixed
ed. The samples were then analyzed by SDS-PAGE and proteins quantified
m.
 Fig. 11. Effect of PrsA concentration on the yield of a-amylase refolding
from preformed SUV–a-amylase complex. SUV suspension (1 ml, 40 AM
lipid) in 0.2 M sodium acetate pH 7 was incubated at 37 jC. After 5 min,
partially folded a-amylase (0.15 AM) was added. The reaction mixture was
divided into fractions of 200 Al to which various amounts of lipomodified
PrsA were added. After 1 h incubation at 37 jC, a-amylase activity was
assayed from an aliquot of each fraction. There was no significant
modification of the results after 3 h incubation. The lipid/PrsA molar ratios
a et Biophysica Acta 1660 (2004) 16–233.4. Presence of PrsA on SUV surface prevents the
interaction between SUVand a-amylase folding intermediate
When SUV were gradually coated with PrsA before
being mixed with a-amylase folding intermediate, we ob-
served (Fig. 8A) that the amount of the unfolded protein
trapped in the lipid phase decreased gradually. Conversely,
the amount of refolded a-amylase recovered in the SUV
supernatant increased (Fig. 8B). When SUV were complete-
ly coated with PrsA, we observed that the kinetic parameters
of the folding transition of the a-amylase folding interme-
diate monitored by fluorescence intensity (Fig. 9A) or
protease sensitivity (Fig. 9B) were in the same order of
magnitude as those measured in the absence of SUV.
3.5. PrsA destabilizes the interaction between SUV and a-
amylase folding intermediate allowing subsequent refolding
We next examined the stability of the SUV–a-amylase
folding intermediate complex in the presence of PrsA. In
such conditions, the refolding transition of a-amylase mon-
itored by fluorescence was slow (Fig. 10). The level of
enzyme activity recovery was approximately 70%, 30 min
after adding PrsA. Two questions can thus be posed: Is PrsA
a catalyst with the a-amylase folding intermediate the
A. Colomer-Pallas et al. / Biochimic22Fig. 10. Kinetics of a-amylase refolding triggered by the addition of PrsA
to preformed SUV–a-amylase complex. SUV suspension (1 ml, 40 AM
lipid) in 0.2 M sodium acetate pH 7 was incubated at 37 jC. After 5 min,
partially folded a-amylase (0.15 AM) was added (arrow 1). Fluorescence
intensity was recorded for 3 min, then lipomodified PrsA (0.25 AM) was
added (arrow 2). The excitation wavelength was 280 nm, and the emission
wavelength was 338 nm. Enlargement of the trace between 300 and 1100 s
is shown in the inset.
are indicated in brackets.substrate or does PrsA destabilize the SUV–a-amylase
interaction because of its high affinity for SUV? The second
hypothesis is supported by the increase of a-amylase
refolding with the PrsA concentration (Fig. 11), which
strongly suggests that the two proteins compete for SUV
binding sites.4. Discussion
Our results indicate that the affinity of a-amylase for
SUV composed of the major membrane lipids of B.
subtilis depends on its conformation. The native form
did not bind vesicles, whereas a partially folded con-
former, stabilized under physiological conditions of pH,
temperature and ionic strength and used as a model for
the competent state for secretion, was able to interact
with the membrane surface of the model membrane to
form a complex preventing the subsequent refolding of
the protein. Since such an interaction takes place at a pH
value higher than the isoelectric point of the protein, it is
tempting to postulate that hydrophobic interactions are
able to overcome the unfavourable electrostatic repulsion.
The exposure of hydrophobic residues at the surface of
the partially folded protein could make partial membrane
insertion easier.
We can rule out that this association is the result of protein
aggregation on the membrane surface for the following
reasons. First, the experiments were carried out at low
A. Colomer-Pallas et al. / Biochimica et Biophysica Acta 1660 (2004) 16–23 23concentrations of protein to prevent any aggregation [17].
Second, we demonstrate here that the association of the
protein with SUV entailed only a modest (30%) quenching
of the amplitude of the intrinsic fluorescence spectrum of the
protein. Moreover, the wavelength of maximal fluorescence
was not red-shifted as one would expect for a denaturation
event. Finally, the association process has been shown to be
much more rapid than the aggregation reaction.
The results obtained in this work show that the B.
subtilis peripheric lipoprotein PrsA modulates the inter-
actions between partially folded conformer of a-amylase
and the membrane surface. The lipomodified form of
PrsA displays a higher affinity for SUV binding sites
than the folding intermediate of a-amylase. PrsA must
either prevent the formation of the SUV–a-amylase
complex or destabilize it. These findings shed light on
the possible effect in vivo of this protein on the process
of protein secretion.
In a recently published work, which was aimed at
characterizing in vivo the role of PrsA, Wahlstrom, et al.
using a very different approach, have also provided evi-
dence that PrsA could prevent unproductive interactions of
exported protein with the negatively charged matrix of the
cytoplasmic membrane–cell wall interface and thus facili-
tate folding [21].
This abundant lipoprotein may be, during protein secre-
tion, an essential component of the micro-environment that
is required for spontaneous folding of secreted proteins
during the secretion process rather than a protein folding
catalyst as previously suggested [11].Acknowledgements
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